Holland High Tech Holland High Tech
Bio-ChipPack

Chip-Packaging co-design for Dermal Biosensing

Continuous Glucose Monitors (CGMs) are a key tool for preventing diabetes by providing continuous insight into blood sugar levels. They are currently used in acute diabetes management, helping to adjust the insulin delivery. The real potential of CGMs, however, lies in their preventive capabilities. Real-time insights into their metabolic state, will help to identify and adjust the lifestyle.

Research for new scalable processes for CGM biosensors.

Within the Bio-ChipPack project a novel, sustainable, and low-cost continuous glucose monitor (CGM) will be developed through the co-design of microneedle biosensors with 3D chip packaging. TU Delft and Sensible will research wafer-level, scalable processes for microneedle fabrication and 3D printing packaging that eliminate the use of PFAS and non-recyclable plastics. New nanostructured materials will be also investigated to improve the sensitivity and reliability of the CGM device while reducing the amount of noble metals used. Compared to existing CGMs, this new CGM will use 40 times less material, enable reusable electronics, and integrate end-of-life processing, drastically reducing e-waste. This innovation will reduce healthcare costs

Facts & figures
  • Scheme: PPS-I Strategische Programma's
  • Programme: Advanced Chip Packaging | 2025-2027
  • Total budgeted project costs: € 1.125.036,00
  • Project start date: 1 January 2026
  • Project end date: 1 December 2028
Project managers
Project consortium
Technische Universiteit Delft Sensible Healthcare Systems
Sign up for our newsletter